Gastroparesis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Gastroparesis, also known as delayed gastric emptying, can be defined as a disease of the stomach muscles or the nerves controlling these muscles that causes the stomach muscles to stop functioning. It affects the spontaneous movement of the stomach muscles. Impaired mobility of the stomach muscles leads to emptying of the stomach. Gastroparesis occurs due to damage to the vagus nerve either because of injury or illness. Gastroparesis that commonly occurs among people is known as idiopathic gastroparesis, indicating that the actual cause of the disease is unclear. Diabetes is other common cause of gastroparesis, as high blood sugar levels leads to slow damage of the vagus nerve causing gastroparesis. The common symptoms of the disease include nausea, feeling of fullness, gastroesophagial reflux, abdominal bloating, lack of appetite, and pain in the stomach area.
The global gastroparesis treatment market is anticipated to record moderate growth during the forecast period. Growth of the market can be attributed to increase in prevalence of diabetes mellitus among people, rise in number of surgeries being performed which could lead to post-operative gastroparesis, introduction of novel drugs, and focus of market players on research and development to launch specific drugs for the treatment of gastroparesis. Additionally, untapped opportunities in the emerging markets such as India and China are likely to fuel the growth of the market. However, usage of non-prescription drugs, side effects of available gastroparesis drugs, and stringent regulatory environment for the approval of new drugs are expected to restrain the market during the forecast period. Moreover, lack of awareness among people about gastroparesis and available treatments is anticipated to hamper market growth.
The global gastroparesis treatment market can be segmented based on drug class, type, distribution channel, and region. In terms of drug class, the market can be categorized into prokinetic agents, botulinum toxin injection, and antiemetic agents. The prokinetic agents segment dominated the market in 2016, owing to effectiveness, ease of availability, high usage, and applicability of these medications in treating gastroparesis. Based on type, the global gastroparesis treatment market can be classified into diabetic gastroparesis, chronic gastroparesis, idiopathic gastroparesis, and post-operative gastroparesis. The post-operative gastroparesis segment is anticipated to expand at a rapid pace during the forecast period, owing to increase in the number of surgeries such as transplantation. In terms of distribution channel, the market can be divided into retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment dominated the market in 2016 and the trend is anticipated to continue during the forecast period.
Geographically, the global gastroparesis treatment market can be segmented into five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America was the largest market in terms of revenue in 2016 and the trend is anticipated to continue during the forecast period. Growth of the market in the region can be attributed to rise in the number of diabetic patients. Diabetic gastroparesis is considered one of the major forms of gastroparesis affecting the population. Europe is expected to be the next attractive market for gastroparesis treatment. However, sluggish economy in the region is likely to hamper the growth of the market. The market in Asia Pacific is anticipated to expand at a high CAGR owing to factors such as government focus on enhancing health care facilities, rise in patient population, and increase in product approvals.
Leading players operating in the global gastroparesis treatment market are Boston Scientific Corporation, Cardinal Health, Inc., C. R. Bard, Inc., Abbott Laboratories, Medtronic, Salix Pharmaceuticals, Inc., Janssen Global Services, LLC, Teva Pharmaceuticals, Kimberly-Clark Corporation, Rhythm Pharmaceuticals, Inc., Alfa Wassermann SPA, and Evoke Pharma, among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017